Dialysis delayed is death prevented: A clinical perspective on the RENAAL study

Kidney International

Volumn 63, Issue 4, 2003, Pages 1577-1579

  Thomas, Merlin C ^a   Cooper, Mark E ^a   Shahinfar, Shahnaz ^a   Brenner, Barry M ^a  

^a NONE

Author keywords

Angiotensin II antagonist; Death; Dialysis; End stage renal disease

Indexed keywords

ANGIOTENSIN II ANTAGONIST; LOSARTAN; PLACEBO;

CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; COST; CREATININE BLOOD LEVEL; DEATH; DIALYSIS; DRUG EFFECT; DYSLIPIDEMIA; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALNUTRITION; MORTALITY; NOTE; OXIDATIVE STRESS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; UREMIA;

EID: 0037379151     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00893.x     Document Type: Note

References (12)

1. NATIONAL KIDNEY FOUNDATION: NKF-DOQI clinical practice guidelines for hemodialysis adequacy. Am J Kidney Dis 30(Suppl 3):S15-S66, 1997
2. OBRADOR G, ARORA P, KAUSZ A, et al: Level of renal function at initiation of dialysis in the U.S. end-stage renal disease population. Kidney Int 56:2227-2235, 1999
3. KAUSZ AT, OBRADOR GT, ARORA P, et al: Late initiation of dialysis among women and ethnic minorities in the United States. J Am Soc Nephrol 11:2351-2357, 2000
4. BRENNER BM, COOPER ME, DE ZEEUW D, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345:861-869, 2001
5. SEKKARIE M, MOSS AH: Witholding and withdrawing dialysis. Am J Kidney Dis 31:464-472, 1998
6. GOLDSMITH DJ, COVlC A: Coronary artery disease in uremia: Etiology, diagnosis, and therapy. Kidney Int 60:2059-2078, 2001
7. SHULMAN NB, FORD CE, HALL WD, et al: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13(Suppl 5):I80-I93, 1989
8. KOREVAAR JC, JANSENC AM, DEKKERD FW, et al: When to initiate dialysis: Effect of proposed US guidelines on survival. 358;1046-1050, 2001
9. WALLEN MD, RADHAKRISHNAN J, APPEL G, et al: An analysis of cardiac mortality in patients with new-onset end-stage renal disease in New York State. Clin Nephrol 55:101-108, 2001
10. WALTERS G, WARWICK G, WALLS J: Analysis of patients dying within one year of starting renal replacement therapy. Am J Nephrol 20:358-363, 2000
11. RUGGENENTI P, PAGANO E, TAMMUZZO L, et al: Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies. Kidney Int 59:286-294, 2001
12. JACOBS C: Demographic and organizational developments of maintenance dialysis therapies. Past, present, outlook into the future. J Nephrol 12(suppl. 2):S47-S52, 1999